Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

nacl

nacl is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 27
News articles 0
Drug details — nacl
Class
—
Route
—
Patents
0
Programs
27
Data quality
0.70
← All drugs Search patents Pipeline programs Drug news hub Event calendar

Quick answer

nacl is an FDA-listed pharmaceutical active ingredient.

Key facts

INN nacl

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 2025-521093-34-00 Phase 3 · PARItec · rare disease
  2. APHP200043 Phase 3 · PARItec · Hemoptysis, whatever the cause, with the exception of cystic
  3. APHP200073 Phase 3 · PARItec · Erythema multiforme (EM) in its severe form managed at the h
  4. APHP210089 Phase 3 · PARItec · Patients hospitalized for allogeneic hematopoietic stem cell
  5. D8610C00001 Phase 3 · AstraZeneca · Respiratory Syncytial Virus and Human Metapneumovirus
  6. Linaclotide 290 micrograms Phase 3 · IRONWOOD PHARMACEUTICALS · Irritable Bowel Syndrome Characterized by Constipation
  7. Linaclotide 290 micrograms Phase 3 · IRONWOOD PHARMACEUTICALS · Chronic Constipation
  8. NL79665.058.22 Phase 3 · Disc Medicine · Cluster headache

Frequently asked questions

What is nacl?

nacl is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.